Metabolomics testing that maps how a cancer feeds and grows, revealing pathways that may be targetable.
Consented intake · your records travel with you · nothing moves without your sign-off
Metabolon studies metabolomics: the small molecules made or used as the body breaks down food, drugs, chemicals, or its own tissue. Because cancers rely on specific metabolic pathways for energy, growth, and survival, mapping them can identify targets for potentially effective therapies. It helps patients understand their cancer's dynamics at the metabolic level.
Prefer the source? Metabolon's own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Metabolon handles billing.
We don't have confirmed insurance details for Metabolon yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Metabolon's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.